Clinical Studies on Cefamezin in Pediatric Field |
Keun Soo Lee, Keun Chan Sohn, Choong Sik Kim, U1 Soon Park |
|
小兒科 領域에서의 Cefamezin 의 臨床的 硏究 |
李議洙, 孫樓寶, 金仲植, 朴己順 |
國立醫療院 小兒科 |
|
|
Abstract |
Clinical studies on Cefamezin, a new Cephalosporin C derivative,
were performed with the following results.
1. Cefamezin was intramuscularly administered in a daily dose of 40〜100 mg/kg to 50 children with various
infections for 3 to 25 days. The therapeutic results were excellent in 37 patients, good
in 7, fair in 5 and no response in 1. The effectiveness rate was 88%
2. No noticeable side effects were observed except frequent loose bowel movement in 3 cases and
mild skin rash in 1 case.
3. Cefamezin was tried in various infections of prematurity and neonatal infant, and could be
appraised as the first drug of choice in neonatal bacterial infections.
|
|